133305-43-8Relevant articles and documents
A pharmaceutical intermediate of PROTAC molecules targeting monoacylglycerol lipase. Preparation method and application
-
Paragraph 0097; 0105-0106, (2021/10/27)
The invention discloses a medical intermediate of PROTAC molecules targeting monoacylglycerol lipase, a preparation method and an application thereof, and relates to the field of medicines. It has the structure shown I: formula I. The hydroxyl end has the
ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS
-
Page/Page column 53-54, (2009/10/22)
The present invention provides a compound of formula (I):said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP- 13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP- 13. Finally, the present invention also provides a pharmaceutical composition.
Immunoassay element containing a diaryl telluride compound to increase its stability
-
Page 9, (2010/02/03)
A dry immunoassay analytical element for assaying a ligand, comprising a support bearing: 1. an enzyme labeled ligand or an enzyme labeled receptor zone; 2. a spreading zone; and 3. a receptor zone containing a fixed concentration of an immobilized recept